ETFs
E
ENTX
Entera Bio Ltd
3.215
+0.275+9.35%Opening13:01 10/20 EDT
OPEN/PREV CLOSE2.940/2.940
TODAY RANGE2.865-3.260
VOL528.32K
MARKET CAP559.16M
52 WEEK RANGE0.9100-4.200
AVG VOL (3M)1.90M
% TURNOVER0.30%
TURNOVER--
P/E (TTM)-9.1831
% RANGE13.44%
EPS(TTM)-0.3501
P/E(FORWARD)-7.9975
P/B21.81
BVPS0.1474
DIVIDEND--
P/S3,572.22
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP528.83M
SHARES OUTSTANDING173.92M
NEXT EARNINGS11/12-11/16
FREE FLOAT164.49M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Benzinga·10/09 12:05
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga·10/09 12:01
Alignment Healthcare, RenX Enterprises And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
TipRanks·10/06 12:36
Entera Bio Strengthens Board with Veteran Biopharma Leader
Seeking Alpha·10/02 14:15
Short Interest Alert: Most and least shorted sub-$2B healthcare stocks in Sep. 2026
NASDAQ·09/25 14:58
Guggenheim Initiates Coverage of Entera Bio with Buy
Dow Jones·09/25 13:07
Entera Bio Initiated at Buy by Guggenheim
Dow Jones·09/25 13:07
Entera Bio Price Target Announced at $11.00/Share by Guggenheim
TipRanks·09/25 08:55
Guggenheim starts Entera with Buy on N-tab platform potential
TipRanks·09/24 22:40
Entera Bio initiated with a Buy at Guggenheim
TipRanks·09/23 13:00
Entera Bio Receives New Overweight Rating From Cantor Fitzgerald (NASDAQ: ENTX)
TipRanks·09/23 11:55
Entera Bio initiated with an Outperform at LifeSci Capital
Benzinga·09/22 10:36
Cantor Fitzgerald Initiates Coverage On Entera Bio with Overweight Rating
Same Industry
Name/Symbol
Change%
Price